Status:
COMPLETED
Atorvastatin in Perioperative Vascular Surgery - Pilot Study
Lead Sponsor:
University of Campinas, Brazil
Conditions:
Vascular Surgery
Eligibility:
All Genders
40-90 years
Phase:
PHASE4
Brief Summary
This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular outcomes ( morta...
Eligibility Criteria
Inclusion
- Vascular surgery (abdominal aortic aneurysm , carotid endarterectomy , limbs revascularization)
Exclusion
- Pregnant or lactating women
- Patient with sensitivity to atorvastatin
- Patient has elevations in certain laboratory values (CK, AST, ALT)
- Known history of active hepatic disease or known hepatic insufficiency
- Patients participating in another clinical trial
- Prior statin therapy to include: \>10 mg of atorvastatin (Lipitor) or \>20 mg of other HMG-CoA Reductase Inhibitors (statins) or use rosuvastatin
- Serious infectious disease after surgery
- Known history of cancer
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00610545
Start Date
July 1 2007
End Date
December 1 2008
Last Update
February 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinics Hospital - State University Campinas
Campinas, São Paulo, Brazil, 13083970